title: The Authors Respond.
authors.forename: Thomas E
authors.initials: TE
authors.lastname: Delea
authors.forename: Jordan
authors.initials: J
authors.lastname: Amdahl
authors.forename: Jose
authors.initials: J
authors.lastname: Diaz
authors.forename: Hamid Reza
authors.initials: HR
authors.lastname: Nakhaipour
authors.forename: Michelle Hackshaw
authors.initials: MH
authors.lastname: El Khoury
mesh_terms: D002292:Carcinoma, Renal Cell / Q000188:drug therapy* / Q000191:economics*; D003362:Cost-Benefit Analysis / Q000191:economics*; D005260:Female; D006801:Humans; D007211:Indoles / Q000191:economics*; D007680:Kidney Neoplasms / Q000188:drug therapy* / Q000191:economics*; D008297:Male; D011743:Pyrimidines / Q000191:economics*; D011758:Pyrroles / Q000191:economics*; D013449:Sulfonamides / Q000191:economics*
chemical_list: D007211:Indoles; D011743:Pyrimidines; D011758:Pyrroles; D013449:Sulfonamides